Gamble Jones Investment Counsel cut its position in shares of Abbott Laboratories ( NYSE:ABT – Get Rating ) by 0.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 218,626 shares of the healthcare product maker's stock after selling 1,059 shares during the period. Abbott Laboratories makes up about 1.8% of Gamble Jones Investment Counsel's portfolio, making the stock its 8th biggest holding. Gamble Jones Investment Counsel's holdings in Abbott Laboratories were worth $24,003,000 at the end of the most recent reporting period.

https://www.dailypolitical.com/2023/05/04/gamble-jones-investment-counsel-has-24-million-stock-holdings-in-abbott-laboratories-nyseabt.html

#dailypolitical